Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
An unstable [t1/2 at 37 degrees = 32 +/- 2 (SD) sec] intermediate, thromboxane A2, was detected in the conversion of prostaglandin G2 into 8-(1-hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid (thromboxane B2) in platelets. The intermediate was trapped by addition of methanol, ethanol, or sodium azide to suspensions of washed human platelets incubated for 30 sec with arachidonic acid or prostaglandin G2. The structures of the resulting derivatives demonstrated that the intermediate possessed an oxane ring as in thromboxane B2 but lacked its hemiacetal hydroxyl group. Additional experiments using 18O2 or [2H8]arachidonic acid in the formation of thromboxane B2 and CH3O2H for the trapping of thromboxane A2, together with information on the t1/2 of the intermediate, indicated the presence of an oxetane structure in thromboxane A2. Incubation of arachidonic acid or prostaglandin G2 with washed platelets led to formation of an unstable factor that induced irreversible platelet aggregation and caused release of [14C]serotonin from platelets that had been incubated with [14C]serotonin. The properties and the mode of formation of this factor indicated that it was identical with thromboxane A2. Furthermore, evidence is presented that the more unstable and major component of rabbit aorta contracting substance (RCS) formed in platelets and guinea pig lung is also thromboxane A2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
Hamberg, M., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3400 · Cited by 1,407
Self-citationIsolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation
Hamberg, M., Svensson, J., Wakabayashi, T., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.2.345 · Cited by 989
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Cited by
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Prostaglandins and Thromboxanes
Samuelsson, B., Goldyne, M., Granström, E., Hamberg, M., Hammarström, S., & Malmsten, C. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.005025 · Cited by 1,299
Self-citationThe mechanism of action of aspirin
Vane, J. R., & Botting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00379-7 · Cited by 1,225
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS
Dyerberg, J., & Bang, H. O. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91490-9 · Cited by 1,001
Gryglewski, R. J., Bunting, S., Moncada, S., Flower, R. J., & Vane, J. R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90047-2 · Cited by 999
Aspirin as an Antiplatelet Drug
Wood, A. J. J., & Patrono, C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301808 · Cited by 955
Biologically active products of stimulated liver macrophages (Kupffer cells)
DECKER, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19222.x · Cited by 904
Moncada, S., Higgs, E. A., & Vane, J. R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91655-5 · Cited by 882
The eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
The composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807
Angiographie morphology and the pathogenesis of unstable angina pectoris
Ambrose, J. A., Winters, S. L., Stern, A., Eng, A., Teichholz, L. E., Gorlin, R., & Fuster, V. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80384-3 · Cited by 801
Anti-inflammatory drugs and their mechanism of action
Vane, J. R., & Botting, R. M. (1998) · Inflammation Research · doi:10.1007/s000110050284 · Cited by 798
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
Prostaglandins, Arachidonic Acid, and Inflammation
Kuehl, F. A., & Egan, R. W. (1980) · Science · doi:10.1126/science.6254151 · Cited by 708
The electronic aggregometer: A novel device for assessing platelet behavior in blood
Cardinal, D. C., & Flower, R. J. (1980) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(80)90024-8 · Cited by 694
Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs
Vane, J. R., & Botting, R. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00203-9 · Cited by 688
Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.
Goodnight, S. H., Harris, W. S., Connor, W. E., & Illingworth, D. R. (1982) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.2.2.87 · Cited by 683
Moncada, S., Herman, A. G., Higgs, E. A., & Vane, J. R. (1977) · Thrombosis Research · doi:10.1016/0049-3848(77)90185-2 · Cited by 680
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
Patrono, C., Ciabattoni, G., Pinca, E., Pugliese, F., Castrucci, G., De Salvo, A., Satta, M. A., & Peskar, B. A. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90066-3 · Cited by 651
Omega-3 fatty acids as cancer chemopreventive agents
Rose, D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00026-1 · Cited by 625
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90048-4 · Cited by 604
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
Tateson, J. E., Moncada, S., & Vane, J. R. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90019-3 · Cited by 600
Hirsh, P. D., Hillis, L. D., Campbell, W. B., Firth, B. G., & Willerson, J. T. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103193041201 · Cited by 594
Wolfe, L. S. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb10847.x · Cited by 573
Dose-Related Kinetics of Aspirin: Presystemic Acetylation of Platelet Cyclooxygenase
Pedersen, A. K., & FitzGerald, G. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111902 · Cited by 558
Inhibition of platelet prostaglandin synthetase by oral aspirin.
Burch, J. W., Stanford, N., & Majerus, P. W. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108941 · Cited by 558
Pulmonary Strategies of Antioxidant Defense
Heffner, J. E., & Repine, J. E. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.2.531 · Cited by 540
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
Needleman, P., Moncada, S., Bunting, S., Vane, J. R., Hamberg, M., & Samuelsson, B. (1976) · Nature · doi:10.1038/261558a0 · Cited by 526
Self-citationInflammation and the mechanism of action of anti‐inflammatory drugs
Vane, J., & Botting, R. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.2.3111928 · Cited by 524
Arteriographic evidence of coronary arterial spasm in acute myocardial infarction.
Oliva, P. B., & Breckinridge, J. C. (1977) · Circulation · doi:10.1161/01.cir.56.3.366 · Cited by 517
Platelet activation: assessment and quantification
Kamath, S. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2515 · Cited by 516
Biosynthesis of Prostaglandins
Lands, W. E. M. (1991) · Annual Review of Nutrition · doi:10.1146/annurev.nu.11.070191.000353 · Cited by 507
Lipocortin and the mechanism of action of the glucocorticoids
Flower, R. J. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11614.x · Cited by 495
Ellis, E. F., Oelz, O., Roberts, L. J., Payne, N. A., Sweetman, B. J., Nies, A. S., & Oates, J. (1976) · Science · doi:10.1126/science.959827 · Cited by 494
Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid
Fischer, S., & Weber, P. C. (1984) · Nature · doi:10.1038/307165a0 · Cited by 471
Martin, J. F., Trowbridge, E. A., Salmon, G., & Plumb, J. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90255-4 · Cited by 466
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Patrono, C., & FitzGerald, G. A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2309 · Cited by 453
Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology
Nakahata, N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.001 · Cited by 443
Prostaglandin and thromboxane biosynthesis
Smith, W. L., Marnett, L. J., & DeWitt, D. L. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90054-p · Cited by 442
Hemler, M., & Lands, W. E. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33098-3 · Cited by 437
Knapp, H. R., Reilly, I. A. G., Alessandrini, P., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141501 · Cited by 415
Dusting, G. J., Moncada, S., & Vane, J. R. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90037-5 · Cited by 412
Bills, T. K., Smith, J. B., & Silver, M. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108745 · Cited by 408
Natural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
Nowak, J., Murray, J. J., Oates, J. A., & FitzGerald, G. A. (1987) · Circulation · doi:10.1161/01.cir.76.1.6 · Cited by 382
Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
Marcus, A. J., Weksler, B. B., Jaffe, E. A., & Broekman, M. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109967 · Cited by 380
The Effect of Physical Exercise on Endothelial Function
Di Francescomarino, S., Sciartilli, A., Di Valerio, V., Di Baldassarre, A., & Gallina, S. (2009) · Sports Medicine · doi:10.2165/11317750-000000000-00000 · Cited by 377
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L.-H., Ma, Y. H., Weinander, R., Jakobsson, P.-J., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206788200 · Cited by 368
COLEMAN, R. A., HUMPHREY, P. P. A., KENNEDY, I., LEVY, G. P., & LUMLEY, P. (1981) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1981.tb16814.x · Cited by 357
Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists
FitzGerald, G. A. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90379-y · Cited by 353
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
Erpenbeck, L., & Schön, M. P. (2010) · Blood · doi:10.1182/blood-2009-10-247296 · Cited by 345
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Engelhardt, G., Homma, D., Schlegel, K., Utzmann, R., & Schnitzler, C. (1995) · Inflammation Research · doi:10.1007/bf01757699 · Cited by 333
Gentile, P., & Garcovich, S. (2019) · Cells · doi:10.3390/cells8050466 · Cited by 333
COX-2 Inhibitors and Cardiovascular Risk
Funk, C. D., & FitzGerald, G. A. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318157f72d · Cited by 330
The aspirin story – from willow to wonder drug
Desborough, M. J. R., & Keeling, D. M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14520 · Cited by 328
Benigni, A., Gregorini, G., Frusca, T., Chiabrando, C., Ballerini, S., Valcamonico, A., Orisio, S., Piccinelli, A., Pinciroli, V., Fanelli, R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210604 · Cited by 326
Biochemistry and physiology of n‐3 fatty acids
Lands, W. E. M. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1592205 · Cited by 323
Effect of Cholesterol on Production of Thromboxane B2by Platelets in Vitro
Stuart, M. J., Gerrard, J. M., & White, J. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020102 · Cited by 321
IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)
Lorenz, R. L., Weber, M., Kotzur, J., Theisen, K., Schacky, C. V., Meister, W., Reichardt, B., & Weber, P. C. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92446-2 · Cited by 320
Platelets and cancer: a casual or causal relationship: revisited
Menter, D. G., Tucker, S. C., Kopetz, S., Sood, A. K., Crissman, J. D., & Honn, K. V. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9498-0 · Cited by 316
Inhibition of prostaglandin biosynthesis by eicosapentaenoic acid
Culp, B. R., Titus, B. G., & Lands, W. E. M. (1979) · Prostaglandins and Medicine · doi:10.1016/0161-4630(79)90068-5 · Cited by 315
The first 3500 years of aspirin history from its roots – A concise summary
Montinari, M. R., Minelli, S., & De Caterina, R. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.10.008 · Cited by 315
5-Hydroxytryptamine receptors in the human cardiovascular system
Kaumann, A. J., & Levy, F. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.12.004 · Cited by 309
Testosterone Increases Human Platelet Thromboxane A2Receptor Density and Aggregation Responses
Ajayi, A. A. L., Mathur, R., & Halushka, P. V. (1995) · Circulation · doi:10.1161/01.cir.91.11.2742 · Cited by 306
Tait, J. F., Gibson, D., & Fujikawa, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83133-7 · Cited by 306
Lipid Metabolism and Ischemic Heart Disease in Greenland Eskimos
Bang, H. O., & Dyerberg, J. (1980) · Advances in Nutritional Research · doi:10.1007/978-1-4757-4448-4_1 · Cited by 299
Indices of lipid peroxidation in vivo: strengths and limitations
Meagher, E. A., & FitzGerald, G. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00232-x · Cited by 299
Possible importance of macrophage-derived mediators in acute malaria
Clark, I. A., Virelizier, J. L., Carswell, E. A., & Wood, P. R. (1981) · Infection and Immunity · doi:10.1128/iai.32.3.1058-1066.1981 · Cited by 296
Pharmacodynamic profile of prostacyclin
Vane, J. R., & Botting, R. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80377-4 · Cited by 292
Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes
Sergeant, S., Rahbar, E., & Chilton, F. H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.020 · Cited by 291
Rodemann, H. P., & Goldberg, A. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68084-1 · Cited by 287
On the mechanism of prostacyclin and thromboxane A2 biosynthesis
Hecker, M., & Ullrich, V (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31235-8 · Cited by 286
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Catella, F., Healy, D., Lawson, J. A., & FitzGerald, G. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5861 · Cited by 286
Mega, J. L., & Simon, T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60243-4 · Cited by 284
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Prostaglandin Synthetase Inhibitors I
Shen, T. Y. (1979) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-66891-3_12 · Cited by 274
MONCADA, S. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09186.x · Cited by 272
Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases
Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266
Jang, Y., Kim, M., & Hwang, S. W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1703-1 · Cited by 263
Garg, M. L., Sebokova, E., Thomson, A. B. R., & Clandinin, M. T. (1988) · Biochemical Journal · doi:10.1042/bj2490351 · Cited by 256
LANDS, W. E. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1323.028 · Cited by 93
Colman, R. W. (1990) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30504-5 · Cited by 12
Metadata
- Authors
- Hamberg, M., Svensson, J., & Samuelsson, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1975-08
- Volume
- 72
- Issue
- 8
- Pages
- 2994-2998
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2030087792
- Cited by
- 3,045
- References
- 3
- FWCI
- 71.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.